Browsing by Author "Almaslamani, Muna A."
Now showing items 1-3 of 3
-
Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic
Al Mana, Hassan; Abdel Hadi, Hamad; Wilson, Godwin; Almaslamani, Muna A.; Abu Jarir, Sulieman H.; Ibrahim, Emad; Eltai, Nahla O.... more authors ... less authors ( MDPI , 2024 , Article)Antimicrobial resistance (AMR) is a global healthcare challenge with substantial morbidity, mortality, and management costs. During the COVID-19 pandemic, there was a documented increase in antimicrobial consumption, ... -
Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination
Zedan, Hadeel T.; Smatti, Maria K.; Thomas, Swapna; Nasrallah, Gheyath K.; Afifi, Nahla M.; Hssain, Ali Ait; Abu Raddad, Laith J.; Coyle, Peter V.; Grivel, Jean Charles; Almaslamani, Muna A.; Althani, Asmaa A.; Yassine, Hadi M.... more authors ... less authors ( American Medical Association , 2023 , Article)Importance: In the ongoing COVID-19 pandemic, there remain unanswered questions regarding the nature and importance of the humoral immune response against other coronaviruses. Although coinfection of the Middle East ... -
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar
Ahmed, Zaqout; Almaslamani, Muna A.; Chemaitelly, Hiam; Hashim, Samar A.; Ittaman, Ajithkumar; Alimam, Abeir; Rustom, Fatma; Daghfal, Joanne; Abukhattab, Mohammed; AlMukdad, Sawsan; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Butt, Adeel A.; Bertollini, Roberto; Al-Khal, Abdullatif; Omrani, Ali S.; Abu-Raddad, Laith J.... more authors ... less authors ( Elsevier , 2022 , Article)ObjectivesTo estimate the real-world effectiveness of sotrovimab against severe, critical, or fatal COVID-19 in Qatar at a time in which most SARS-CoV-2 incidences occurred due to the BA.2 Omicron subvariant. MethodsWe ...